1. |
Johnson EO, Zoubos AB, Soucacos PN. Regeneration and repair of peripheral nerves. Injury, 2005, 36 Suppl 4: S24-S29. doi: 10.1016/j.injury.2005.10.012.
|
2. |
Gu X, Ding F, Yang Y, et al. Construction of tissue engineered nerve grafts and their application in peripheral nerve regeneration. Prog Neurobiol, 2011, 93(2): 204-230.
|
3. |
Alluin O, Wittmann C, Marqueste T, et al. Functional recovery after peripheral nerve injury and implantation of a collagen guide. Biomaterials, 2009, 30(3): 363-373.
|
4. |
Hudson TW, Liu SY, Schmidt CE. Engineering an improved acellular nerve graft via optimized chemical processing. Tissue Eng, 2004, 10(9-10): 1346-1358.
|
5. |
Levi-Montalcini R, Skaper SD, Dal Toso R, et al. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci, 1996, 19(11): 514-520.
|
6. |
Porrett PM, Orandi BJ, Kumar V, et al. First clinical-grade porcine kidney xenotransplant using a human decedent model. Am J Transplant, 2022, 22(4): 1037-1053.
|
7. |
Ekser B, Rigotti P, Gridelli B, et al. Xenotransplantation of solid organs in the pig-to-primate model. Transpl Immunol, 2009, 21(2): 87-92.
|
8. |
Stahl EC, Bonvillain RW, Skillen CD, et al. Evaluation of the host immune response to decellularized lung scaffolds derived from α-Gal knockout pigs in a non-human primate model. Biomaterials, 2018, 187: 93-104.
|
9. |
刘梅珍, 王立人, 李咏梅, 等. 利用CRISPR/Cas9技术构建基因编辑大鼠模型. 遗传, 2023, 45(1): 78-88.
|
10. |
Griffith BP, Goerlich CE, Singh AK, et al. Genetically modified porcine-to-human cardiac xenotransplantation. N Engl J Med, 2022, 387(1): 35-44.
|
11. |
Montgomery RA, Stern JM, Lonze BE, et al. Results of two cases of pig-to-human kidney xenotransplantation. N Engl J Med, 2022, 386(20): 1889-1898.
|
12. |
Battiston B, Titolo P, Ciclamini D, et al. Peripheral nerve defects: overviews of practice in Europe. Hand Clin, 2017, 33(3): 545-550.
|
13. |
Moffat D, Ye K, Jin S. Decellularization for the retention of tissue niches. J Tissue Eng, 2022, 13: 20417314221101151. doi: 10.1177/20417314221101151.
|
14. |
Cooper DK, Keogh AM. The potential role of xenotransplantation in treating endstage cardiac disease: a summary of the report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation. Curr Opin Cardiol, 2001, 16(2): 105-109.
|
15. |
Tearle RG, Tange MJ, Zannettino ZL, et al. The alpha-1, 3-galactosyltransferase knockout mouse. Implications for xenotransplantation. Transplantation, 1996, 61(1): 13-19.
|
16. |
Galili U, Rachmilewitz EA, Peleg A, et al. A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med, 1984, 160(5): 1519-1531.
|
17. |
Raeder RH, Badylak SF, Sheehan C, et al. Natural anti-galactose alpha1, 3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts. Transpl Immunol, 2002, 10(1): 15-24.
|
18. |
Serrano M C, Nardecchia S, García-Rama C, et al. Chondroitin sulphate-based 3D scaffolds containing MWCNTs for nervous tissue repair. Biomaterials, 2014, 35(5): 1543-1551.
|
19. |
Kang SW, Rahman MS, Kim AN, et al. Comparative study of the quality characteristics of defatted soy flour treated by supercritical carbon dioxide and organic solvent. J Food Sci Technol, 2017, 54(8): 2485-2493.
|